News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
701,369 Results
Type
Article (40876)
Company Profile (272)
Press Release (660221)
Multimedia
Podcasts (49)
Webinars (12)
Section
Business (205396)
Career Advice (2035)
Deals (35536)
Drug Delivery (96)
Drug Development (81323)
Employer Resources (172)
FDA (16206)
Job Trends (14916)
News (346842)
Policy (32656)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (5)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2601)
Accelerated approval (5)
Adcomms (21)
Allergies (81)
Alliances (49804)
ALS (86)
Alzheimer's disease (1376)
Antibody-drug conjugate (ADC) (114)
Approvals (16210)
Artificial intelligence (235)
Autoimmune disease (20)
Automation (14)
Bankruptcy (362)
Best Places to Work (11666)
BIOSECURE Act (19)
Biosimilars (103)
Biotechnology (191)
Bladder cancer (60)
Brain cancer (26)
Breast cancer (257)
Cancer (2054)
Cardiovascular disease (164)
Career advice (1700)
Career pathing (29)
CAR-T (143)
Cell therapy (402)
Cervical cancer (19)
Clinical research (65982)
Collaboration (786)
Compensation (486)
Complete response letters (19)
COVID-19 (2605)
CRISPR (38)
C-suite (220)
Cystic fibrosis (99)
Data (2025)
Decentralized trials (2)
Denatured (19)
Depression (39)
Diabetes (254)
Diagnostics (6368)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (116)
Drug pricing (97)
Drug shortages (25)
Duchenne muscular dystrophy (88)
Earnings (86387)
Editorial (32)
Employer branding (21)
Employer resources (146)
Events (112393)
Executive appointments (675)
FDA (17358)
Featured Employer (48)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (710)
Gene editing (101)
Generative AI (19)
Gene therapy (283)
GLP-1 (694)
Government (4414)
Grass and pollen (4)
Guidances (50)
Healthcare (18870)
Huntington's disease (23)
IgA nephropathy (24)
Immunology and inflammation (109)
Indications (26)
Infectious disease (2743)
Inflammatory bowel disease (136)
Inflation Reduction Act (10)
Influenza (50)
Intellectual property (89)
Interviews (313)
IPO (16529)
IRA (42)
Job creations (3668)
Job search strategy (1447)
Kidney cancer (9)
Labor market (34)
Layoffs (463)
Leadership (16)
Legal (7950)
Liver cancer (71)
Lung cancer (298)
Lymphoma (136)
Machine learning (4)
Management (58)
Manufacturing (275)
MASH (62)
Medical device (13353)
Medtech (13358)
Mergers & acquisitions (19501)
Metabolic disorders (648)
Multiple sclerosis (72)
NASH (16)
Neurodegenerative disease (84)
Neuropsychiatric disorders (24)
Neuroscience (1879)
NextGen: Class of 2025 (6566)
Non-profit (4500)
Northern California (2497)
Now hiring (37)
Obesity (347)
Opinion (206)
Ovarian cancer (73)
Pain (80)
Pancreatic cancer (80)
Parkinson's disease (143)
Partnered (20)
Patents (211)
Patient recruitment (99)
Peanut (46)
People (57730)
Pharmaceutical (67)
Pharmacy benefit managers (18)
Phase I (20573)
Phase II (29048)
Phase III (21644)
Pipeline (1082)
Policy (121)
Postmarket research (2578)
Preclinical (8727)
Press Release (64)
Prostate cancer (95)
Psychedelics (30)
Radiopharmaceuticals (244)
Rare diseases (365)
Real estate (5955)
Recruiting (65)
Regulatory (22259)
Reports (46)
Research institute (2341)
Resumes & cover letters (350)
Rett syndrome (4)
RNA editing (4)
RSV (39)
Schizophrenia (65)
Series A (126)
Series B (79)
Service/supplier (13)
Sickle cell disease (51)
Southern California (2160)
Special edition (14)
Spinal muscular atrophy (148)
Sponsored (28)
Startups (3649)
State (2)
Stomach cancer (13)
Supply chain (62)
Tariffs (14)
The Weekly (28)
United States (21714)
Vaccines (664)
Venture capitalists (38)
Weight loss (227)
Women's health (34)
Worklife (15)
Date
Today (94)
Last 7 days (463)
Last 30 days (2553)
Last 365 days (33276)
2025 (8716)
2024 (35369)
2023 (40219)
2022 (51344)
2021 (55886)
2020 (54220)
2019 (46724)
2018 (35181)
2017 (32285)
2016 (31707)
2015 (37796)
2014 (31539)
2013 (26630)
2012 (28894)
2011 (29539)
2010 (27634)
Location
Africa (725)
Alabama (51)
Alaska (7)
Arizona (227)
Arkansas (13)
Asia (37999)
Australia (6232)
California (5689)
Canada (1909)
China (483)
Colorado (250)
Connecticut (260)
Delaware (132)
Europe (81594)
Florida (845)
Georgia (198)
Idaho (58)
Illinois (508)
India (25)
Indiana (296)
Iowa (9)
Japan (147)
Kansas (103)
Kentucky (23)
Louisiana (9)
Maine (62)
Maryland (844)
Massachusetts (4285)
Michigan (213)
Minnesota (376)
Mississippi (2)
Missouri (78)
Montana (27)
Nebraska (25)
Nevada (57)
New Hampshire (63)
New Jersey (1624)
New Mexico (28)
New York (1621)
North Carolina (931)
North Dakota (7)
Northern California (2497)
Ohio (196)
Oklahoma (14)
Oregon (34)
Pennsylvania (1284)
Puerto Rico (10)
Rhode Island (29)
South America (1102)
South Carolina (18)
South Dakota (1)
Southern California (2160)
Tennessee (96)
Texas (846)
Utah (168)
Virginia (136)
Washington D.C. (60)
Washington State (527)
West Virginia (3)
Wisconsin (50)
701,369 Results for "harvard bioscience inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Harvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025
March 13, 2025
·
1 min read
Press Releases
Harvard Bioscience, Inc. to Participate in the Sidoti Micro Cap Conference
January 14, 2025
·
1 min read
Press Releases
Harvard Bioscience Announces Fourth Quarter and Full-Year 2024 Financial Results
March 12, 2025
·
13 min read
Genetown
Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024
Harvard Bioscience, Inc. announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be presenting to investors at the Jefferies Global Healthcare Conference at the Marriott Marquis in New York City on June 5, 2024.
May 23, 2024
·
1 min read
Genetown
Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference
Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be participating in the Benchmark Healthcare House Call Virtual Conference on May 22nd, 2024, with a live fireside chat scheduled for 9:00-9:40 am ET.
May 16, 2024
·
1 min read
Press Releases
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting
February 24, 2025
·
3 min read
Press Releases
Andelyn Biosciences Expands AAV Curator™ Platform Offering to Include Stanton Lab CNS Capsids through a License Agreement from the Broad Institute of MIT and Harvard
February 19, 2025
·
3 min read
Genetown
Harvard Bioscience, Inc. to Present and Host One-on-One Meetings at the 14th Annual East Coast IDEAS Conference on June 12, 2024
Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be presenting to investors at the 14th Annual East Coast IDEAS Conference at the Jay Conference Center – Bryant Park in New York City on June 12, 2024.
June 6, 2024
·
1 min read
Press Releases
Harvard Bioscience Schedules Fourth Quarter 2024 Earnings Conference Call for March 12, 2025 at 8:00 AM ET
February 25, 2025
·
1 min read
Business
Harvard Bioscience Announces First Quarter 2024 Financial ResultsStrong gross margin performance and focus on efficiency to support ongoing investments in growth
Harvard Bioscience, Inc. announced financial results for the first quarter ended March 31, 2024.
May 7, 2024
·
10 min read
1 of 70,137
Next
